Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Clinical dilemmas in inflammatory bowel disease [[electronic resource] /] / edited by Peter Irving, David Rampton, Fergus Shanahan
| Clinical dilemmas in inflammatory bowel disease [[electronic resource] /] / edited by Peter Irving, David Rampton, Fergus Shanahan |
| Pubbl/distr/stampa | Malden, MA, : Blackwell Pub. Ltd, 2006 |
| Descrizione fisica | 1 online resource (264 p.) |
| Disciplina | 616.344 |
| Altri autori (Persone) |
IrvingPeter <1970->
RamptonDavid ShanahanFergus |
| Soggetto topico |
Inflammatory bowel diseases
Inflammatory bowel diseases - Decision making |
| ISBN |
1-281-32207-5
9786611322076 0-470-75082-0 0-470-75028-6 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Clinical Dilemmas in: Inflammatory Bowel Disease; Contents; List of Contributors; Preface; Part 1 Investigating IBD in the 21st Century; 1 Capsule endoscopy: do we need it?; 2 Pathology reports - pitfalls for the unwary; 3 Non-invasive diagnosis and assessment; 4 What is the best way to image perianal Crohn's disease?; 5 Surveillance colonoscopy in UC: alternatives and ways to improve outcome; 6 Abnormal liver tests - what should we do about them?; Part 2 Medical Treatment: Making the Most of What We've Got - 5-ASA drugs; 5-ASA drugs; 7 Is monitoring necessary?
8 Do they have a role in Crohn's disease?Steroids; 9 Steroids in Crohn's: are they obsolete?; Antibiotics for Crohn's disease; 10 Antibiotics: which, when, and for how long?; 11 M ycobacterium av ium paratuberculosis in Crohn's disease: player or spectator?; Immunomodulators; 12 TPMT testing: is it essential?; 13 6-Mercaptopurine or azathioprine?; 14 Thiopurines: how long should we use them for?; 15 Making the most of methotrexate; 16 Cyclosporine: balancing risk and benefit; Infliximab; 17 Contraindications - absolute or relative?; 18 How can we prevent tuberculosis? 19 Dealing with infusion reactions20 Use in ulcerative colitis; 21 Infliximab and surgery: health or hazard?; Nutritional therapy for Crohn's disease; 22 Nutritional therapy for Crohn's disease: is it for adults?; Part 3 Medical Treatment: What's Round the Corner?; 23 Trials and tribulations - interpreting clinical trials in IBD; 24 Genetics - clinical and therapeutic applications; 25 Probiotics - separating science from snakeoil; 26 Worms; 27 Smoking and nicotine - poison for Crohn's, potion for colitis?; 28 Heparin; 29 Leukocytapheresis: filtering out the facts 30 Appendectomy for ulcerative colitis - a therapeutic option?31 Biologic treatments in IBD; 32 Stem cell transplantation for IBD; 33 Complementary and alternative therapy - the way forward or a step back?; Part 4 Common Clinical Challenges: Beyond the Text Book; 34 Functional problems; 35 Psychological stress: something to worry about?; 36 Drugs to avoid; 37 NSAIDs and COX-2 selective agents: cause or cure of pain in IBD?; 38 Iron replacement - is it safe and effective?; 39 Hepatitis B and C viruses - how do they affect management of IBD?; 40 Pregnancy: what drugs can we use? 41 How to prevent growth failure in children42 Predicting outcome in severe UC; 43 Refractory proctitis; 44 CMV co-infection - does it matter?; 45 Treatment of oral Crohn's disease; 46 Pathophysiologic approach to treatment of diarrhea in Crohn's disease; 47 Short bowel; 48 Management of internal fistulae; 49 What is indeterminate colitis?; 50 Pouches for indeterminate colitis?; 51 Colitis-associated cancer: what's the risk to your patients?; 52 What to do with dysplasia, DALMs, and adenomas; Part 5 Managing IBD Outside the Gut; 53 Pyoderma gangrenosum 54 Arthritides - helping the joints without harming the gut |
| Record Nr. | UNINA-9910784972003321 |
| Malden, MA, : Blackwell Pub. Ltd, 2006 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Clinical dilemmas in inflammatory bowel disease [[electronic resource] /] / edited by Peter Irving, David Rampton, Fergus Shanahan
| Clinical dilemmas in inflammatory bowel disease [[electronic resource] /] / edited by Peter Irving, David Rampton, Fergus Shanahan |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Malden, MA, : Blackwell Pub. Ltd, 2006 |
| Descrizione fisica | 1 online resource (264 p.) |
| Disciplina | 616.344 |
| Altri autori (Persone) |
IrvingPeter <1970->
RamptonDavid ShanahanFergus |
| Soggetto topico |
Inflammatory bowel diseases
Inflammatory bowel diseases - Decision making |
| ISBN |
1-281-32207-5
9786611322076 0-470-75082-0 0-470-75028-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Clinical Dilemmas in: Inflammatory Bowel Disease; Contents; List of Contributors; Preface; Part 1 Investigating IBD in the 21st Century; 1 Capsule endoscopy: do we need it?; 2 Pathology reports - pitfalls for the unwary; 3 Non-invasive diagnosis and assessment; 4 What is the best way to image perianal Crohn's disease?; 5 Surveillance colonoscopy in UC: alternatives and ways to improve outcome; 6 Abnormal liver tests - what should we do about them?; Part 2 Medical Treatment: Making the Most of What We've Got - 5-ASA drugs; 5-ASA drugs; 7 Is monitoring necessary?
8 Do they have a role in Crohn's disease?Steroids; 9 Steroids in Crohn's: are they obsolete?; Antibiotics for Crohn's disease; 10 Antibiotics: which, when, and for how long?; 11 M ycobacterium av ium paratuberculosis in Crohn's disease: player or spectator?; Immunomodulators; 12 TPMT testing: is it essential?; 13 6-Mercaptopurine or azathioprine?; 14 Thiopurines: how long should we use them for?; 15 Making the most of methotrexate; 16 Cyclosporine: balancing risk and benefit; Infliximab; 17 Contraindications - absolute or relative?; 18 How can we prevent tuberculosis? 19 Dealing with infusion reactions20 Use in ulcerative colitis; 21 Infliximab and surgery: health or hazard?; Nutritional therapy for Crohn's disease; 22 Nutritional therapy for Crohn's disease: is it for adults?; Part 3 Medical Treatment: What's Round the Corner?; 23 Trials and tribulations - interpreting clinical trials in IBD; 24 Genetics - clinical and therapeutic applications; 25 Probiotics - separating science from snakeoil; 26 Worms; 27 Smoking and nicotine - poison for Crohn's, potion for colitis?; 28 Heparin; 29 Leukocytapheresis: filtering out the facts 30 Appendectomy for ulcerative colitis - a therapeutic option?31 Biologic treatments in IBD; 32 Stem cell transplantation for IBD; 33 Complementary and alternative therapy - the way forward or a step back?; Part 4 Common Clinical Challenges: Beyond the Text Book; 34 Functional problems; 35 Psychological stress: something to worry about?; 36 Drugs to avoid; 37 NSAIDs and COX-2 selective agents: cause or cure of pain in IBD?; 38 Iron replacement - is it safe and effective?; 39 Hepatitis B and C viruses - how do they affect management of IBD?; 40 Pregnancy: what drugs can we use? 41 How to prevent growth failure in children42 Predicting outcome in severe UC; 43 Refractory proctitis; 44 CMV co-infection - does it matter?; 45 Treatment of oral Crohn's disease; 46 Pathophysiologic approach to treatment of diarrhea in Crohn's disease; 47 Short bowel; 48 Management of internal fistulae; 49 What is indeterminate colitis?; 50 Pouches for indeterminate colitis?; 51 Colitis-associated cancer: what's the risk to your patients?; 52 What to do with dysplasia, DALMs, and adenomas; Part 5 Managing IBD Outside the Gut; 53 Pyoderma gangrenosum 54 Arthritides - helping the joints without harming the gut |
| Record Nr. | UNINA-9910825090603321 |
| Malden, MA, : Blackwell Pub. Ltd, 2006 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Clinical dilemmas in inflammatory bowel disease [[electronic resource] /] / edited by Peter Irving, David Rampton, Fergus Shanahan
| Clinical dilemmas in inflammatory bowel disease [[electronic resource] /] / edited by Peter Irving, David Rampton, Fergus Shanahan |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Malden, MA, : Blackwell Pub. Ltd, 2006 |
| Descrizione fisica | 1 online resource (264 p.) |
| Disciplina | 616.344 |
| Altri autori (Persone) |
IrvingPeter <1970->
RamptonDavid ShanahanFergus |
| Soggetto topico |
Inflammatory bowel diseases
Inflammatory bowel diseases - Decision making |
| ISBN |
1-281-32207-5
9786611322076 0-470-75082-0 0-470-75028-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Clinical Dilemmas in: Inflammatory Bowel Disease; Contents; List of Contributors; Preface; Part 1 Investigating IBD in the 21st Century; 1 Capsule endoscopy: do we need it?; 2 Pathology reports - pitfalls for the unwary; 3 Non-invasive diagnosis and assessment; 4 What is the best way to image perianal Crohn's disease?; 5 Surveillance colonoscopy in UC: alternatives and ways to improve outcome; 6 Abnormal liver tests - what should we do about them?; Part 2 Medical Treatment: Making the Most of What We've Got - 5-ASA drugs; 5-ASA drugs; 7 Is monitoring necessary?
8 Do they have a role in Crohn's disease?Steroids; 9 Steroids in Crohn's: are they obsolete?; Antibiotics for Crohn's disease; 10 Antibiotics: which, when, and for how long?; 11 M ycobacterium av ium paratuberculosis in Crohn's disease: player or spectator?; Immunomodulators; 12 TPMT testing: is it essential?; 13 6-Mercaptopurine or azathioprine?; 14 Thiopurines: how long should we use them for?; 15 Making the most of methotrexate; 16 Cyclosporine: balancing risk and benefit; Infliximab; 17 Contraindications - absolute or relative?; 18 How can we prevent tuberculosis? 19 Dealing with infusion reactions20 Use in ulcerative colitis; 21 Infliximab and surgery: health or hazard?; Nutritional therapy for Crohn's disease; 22 Nutritional therapy for Crohn's disease: is it for adults?; Part 3 Medical Treatment: What's Round the Corner?; 23 Trials and tribulations - interpreting clinical trials in IBD; 24 Genetics - clinical and therapeutic applications; 25 Probiotics - separating science from snakeoil; 26 Worms; 27 Smoking and nicotine - poison for Crohn's, potion for colitis?; 28 Heparin; 29 Leukocytapheresis: filtering out the facts 30 Appendectomy for ulcerative colitis - a therapeutic option?31 Biologic treatments in IBD; 32 Stem cell transplantation for IBD; 33 Complementary and alternative therapy - the way forward or a step back?; Part 4 Common Clinical Challenges: Beyond the Text Book; 34 Functional problems; 35 Psychological stress: something to worry about?; 36 Drugs to avoid; 37 NSAIDs and COX-2 selective agents: cause or cure of pain in IBD?; 38 Iron replacement - is it safe and effective?; 39 Hepatitis B and C viruses - how do they affect management of IBD?; 40 Pregnancy: what drugs can we use? 41 How to prevent growth failure in children42 Predicting outcome in severe UC; 43 Refractory proctitis; 44 CMV co-infection - does it matter?; 45 Treatment of oral Crohn's disease; 46 Pathophysiologic approach to treatment of diarrhea in Crohn's disease; 47 Short bowel; 48 Management of internal fistulae; 49 What is indeterminate colitis?; 50 Pouches for indeterminate colitis?; 51 Colitis-associated cancer: what's the risk to your patients?; 52 What to do with dysplasia, DALMs, and adenomas; Part 5 Managing IBD Outside the Gut; 53 Pyoderma gangrenosum 54 Arthritides - helping the joints without harming the gut |
| Record Nr. | UNISA-996201971203316 |
| Malden, MA, : Blackwell Pub. Ltd, 2006 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||